Showing results (941-950 of 6,768) with videos related to

Sort By:
Pageof 677
Clinical Therapeutics|March 16, 2013
Coronary hypersensitivity disorder: the Kounis syndromeNicholas G Kounis
Clinical Therapeutics|March 16, 2013
The economic burden of treatment-resistant depressionNatalia Olchanski, Michelle McInnis Myers, Marilyn Halseth, et al.
Clinical Therapeutics|March 19, 2013
Lack of clinically relevant drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and verapamil, ramipril, or digoxin in healthy volunteersSreeraj Macha, Regina Sennewald, Peter Rose, et al.
Clinical Therapeutics|March 19, 2013
Budget impact modeling for a single-tablet formulation of ibuprofen and famotidine for prevention of upper gastrointestinal ulcers in patients with osteoarthritis and/or rheumatoid arthritisRenee Kuan, Robert J Holt, Kenneth E Johnson, et al.
Clinical Therapeutics|March 1, 1990
Effects of pindolol on serum lipoproteins and postheparin lipolytic activities in hypertensive patientsN Sasaki, Y Saito, M Shinomiya, et al.
Clinical Therapeutics|May 7, 2013
Retrospective real-world adherence in patients with type 2 diabetes initiating once-daily liraglutide 1.8 mg or twice-daily exenatide 10 μgMaria Malmenäs, Jonathan R Bouchard, Jakob Langer
Clinical Therapeutics|January 19, 2013
A randomized, open-label, crossover study to evaluate the pharmacokinetics of empagliflozin and linagliptin after coadministration in healthy male volunteersChristian Friedrich, Katrin Metzmann, Peter Rose, et al.
Clinical Therapeutics|January 19, 2013
Short and long-term outcomes from a multisession diabetes education program targeting low-income minority patients: a six-month follow upJohn G Ryan, Terri Jennings, Isabel Vittoria, et al.
Clinical Therapeutics|January 30, 2013
Medication beliefs and self-reported adherence among community-dwelling older adultsJo Anne Sirey, Alexandra Greenfield, Mark I Weinberger, et al.
Clinical Therapeutics|February 16, 2013
Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical studyHui-liang Liu, Yong Yang, Sheng-li Yang, et al.
Pageof 677